Beta Bionics faces a class action lawsuit for allegedly misleading investors about the safety and effectiveness of its iLet Bionic Pancreas insulin pump. The company claimed FDA concerns were minor and unrelated to device safety, but the FDA's warning letter revealed serious device malfunctions causing dangerous insulin overdoses and life-threatening events. The stock price dropped from $31.99 to $12.89 after these disclosures. Investors who bought Beta Bionics stock between July 30, 2025, and February 24, 2026, may join the lawsuit before the November 3, 2026 deadline.
Oracle's stock price has fallen 54% from its highest point, marking a significant decline. Historically, when Oracle experienced a similar drop, it took more than ten years for the stock to recover fully. This long recovery period highlights potentia...
Wallets tied to North Korea's sanctioned Lazarus Group have moved over $30 million in stolen cryptocurrency through Hyperliquid's decentralized trading platform as recently as August 30. These funds were converted across multiple blockchains before r...
Bitwise Asset Management's XRP spot ETF has reached over $500 million in assets under management just nine months after launching on the NYSE in November 2025. This milestone is notable as it occurred despite a significant decline in XRP's price, ind...
Tenor OTC, a non-custodial lending platform powered by Morpho Midnight, has added Aerodrome's AERO token as collateral for fixed-rate borrowing on the Base network. This allows AERO holders to secure loans without selling their tokens, maintaining th...
An Amazon cargo plane operated by 21 Air overran the runway at Miami International Airport on Sept. 6, 2026, crashing into vehicles and killing at least five people while injuring five others. The Boeing 767-300, arriving from San Juan, Puerto Rico, ...
